Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on January 29, 2018. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

N6264517C4023

Awarded
N6264517R0081Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 6 hours ago

DEADLINE

in 12 months
NAICS: 541715
New
Federal
L-PBF Development of ODS Alloys for Recording Methane/Oxygen Combustion Properties
Solicitation # 80NSSC27946801Q
The NASA Shared Services Center is seeking capability statements for a project focused on the laser powder bed fusion (L-PBF) development of oxide dispersion strengthened (ODS) and burn-resistant nickel-based alloys, including GRX-810, GRX-810+, and GRX-900. The scope of work involves advanced process development and parameter optimization using an EOS M280 system to achieve a relative density of 99.9 percent or higher. Key requirements include the production of test coupons and representative components, the supply of at least 600 kg of GRX-810 powder, and strict adherence to NASA-STD-6030 for mechanical validation. All deliverables must be shipped to the Marshall Space Flight Center in Huntsville, Alabama. This procurement is being conducted as a commercial items or services acquisition under FAR Part 12, with NAICS code 541715. NASA intends to issue a sole source contract to North American Manufacturing Pros LLC under FAR 12.102(a); however, the agency is requesting capability statements from other interested organizations to determine if the procurement should be conducted on a competitive basis. Interested parties must submit their qualifications to the primary point of contact, Cara Craft, by October 22, 2026. The contract requires rigorous documentation, including real-time reporting of anomalies and full powder traceability certifications covering chemical composition and particle morphology.
NASA Shared Services Center

POSTED

1 day ago

DEADLINE

in 2 days
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in 17 days
NAICS: 541715
New
Federal
Request for Information – Prophylactic Platform for Medical Countermeasures
Solicitation # W911SR27SPPFC
The Department of Defense, through the Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND) and the Accelerated Defense Pharmaceuticals (ADP) program, is issuing a Request for Information (RFI) under solicitation W911SR27SPPFC. The objective is to identify capable companies that can advance the development of prophylactic medical countermeasures (MCMs) using existing platform technologies. The program focuses on progressing these countermeasures through Phase I or Phase II clinical trials, with a goal of enabling interim fielding via Expanded Access Protocols or pre-Emergency Use Authorization. The anticipated period of performance is up to four years, with work primarily conducted at the contractor's facilities. Interested respondents must provide a comprehensive capability description, including technical approach, regulatory status with the FDA, cGMP manufacturing capabilities, and a development roadmap with rough order of magnitude cost estimates. Evaluation criteria for future selections will emphasize manufacturing process capability, product safety and efficacy, past FDA experience, and the plug-and-play nature of the platform across various pathogens. Submissions must be delivered as a single searchable PDF, featuring a specific cover page and a core capability description not exceeding four pages. All non-clinical and clinical data must be SEND and CDISC compliant, and manufacturing must adhere to cGMP standards to support an Investigational New Drug application through a Biologics License Application.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

in 29 days

AI Contract Overview

Show more

The Naval Medical Logistics Command is awarding a sole-source, cost-plus-fixed-fee bridge contract to Leidos, Inc. to provide critical research and development support services for the Naval Submarine Medical Research Laboratory in Groton, Connecticut. This requirement focuses on human-centric research solutions involving medical, psychological, and physiological investigations to maintain the health and performance of naval personnel in the undersea domain. The contract is justified under 10 U.S.C. 2304(c)(1) and FAR 6.302-1 to prevent a detrimental break in vital services caused by administrative delays in the requirements package and staffing shortages within the contracting office. The base period of performance runs from September 1, 2017, to February 28, 2018, with three additional one-month option periods extending the potential total performance to nine months. The estimated total contract value is 3,929,115.00 dollars, funded through Fiscal Year 2017 and 2018 Research, Development, Test and Evaluation funds. This bridge action serves as a temporary measure to ensure continuity of operations while the government prepares a full and open competition for a subsequent five-year service vehicle.

General Info

Contract Value

$2,730,994.05

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Naval Submarine Medical Research Laboratory - Groton, GROTON, CT, 06349-5900, USA

Set-Aside

NONE

Award Issued Date

Documents

1

Justification and Approval for Sole Source Bridge Contract

PDF, High priority: read this firstjustification-and-approval
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseAwarded
Posted

special-notice

Justification (J&A)

Justification & Approval published

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Naval Medical Logistics Command
Contacts2 people available
OfficeFORT DETRICK, MD, 21702-9203, USA
Office AddressFORT DETRICK, MD, 21702-9203, USA
Contacts
Jennifer M. ReedContract Specialist
Thomas L. HoodContracting Officer

Full Description

Show more
J&A Number: 17-10166 JUSTIFICATION AND APPROVAL FOR USE OF OTHER THAN FULL AND OPEN COMPETITION 1. Contracting Activity. The Naval Medical Logistics Command (NMLC), Fort Detrick, MD is the contracting activity. The requiring activity is the Naval Submarine Medical Research Laboratory (NSMRL), located at the Naval Submarine Base New London, Box 900, Groton, CT 06349-5900. 2. Description of the Action Being Approved. The contract action being approved is an award for a cost-plus-fixed-fee (CPFF) bridge contract, on a sole source basis, in order to provide research and development support services for the purposes of NSMRL research efforts. The proposed source is Leidos, Inc. (Cage: 5UTE2) (incumbent under the current contract: N62645-12-C-4075). Leidos, Inc. is located at 11951 Freedom Dr., Reston, VA, 20190-5640. 3. Description of Supplies/Services. This requirement is for research support services to be provided at NSMRL, located in Groton, CT. The research conducted at NSMRL provides human-centric research solutions, aligned with Submarine Force strategic direction, to sustain superiority in the undersea domain. This requirement requires research and development investigations of medical, psychological, physiological, and other issues associated with the health and performance of naval personnel in operational and non-operational settings. The base period of performance (POP) is 01 September 2017 to 28 February 2018 (6 months). There will be three (3) additional one-month option periods as follows: option period one will have a POP of 01 March 2018 to 31 March 2018, option period two will have a POP of 01 April 2018 to 30 April 2018, and option period three will have a POP of 01 May 2018 to 31 May 2018. The entire contract action results in a potential total of 9 months of performance (if all options are exercised). The estimated total contract value of this contract action (if all options are exercised) is $3,929,115.00, which will be funded incrementally. The type of funds being utilized are Research, Development, Test and Evaluation (RDT&E) funds for Fiscal Years (FY) 2017 and 2018. 4. Statutory Authority Permitting Other Than Full and Open Competition. 10 U.S.C. 2304(c)(1), One source. (FAR 6.302-1) 5. Rationale Justifying Use of Cited Statutory Authority. Contract N62645-12-C-4075 was awarded through full and open competition to Leidos, Inc. N62645-12-C-4075 currently provides research support services at NSMRL. N62645-12-C-4075 has a total contract value of over $22 million dollars and has a period of performance end date of 31 August 2017. The follow on contract to N62645-12-C-4075 must start providing services by 01 September 2017 to prevent a detrimental break in services. The published NMLC Published Action Lead Time (PALT) for service contracts under $50 million dollars is 182 days. The 182 day timeline is after the receipt of a complete requirements package. A complete requirements package consists of a Performance Work Statement (PWS) with a Quality Assurance Surveillance Plan (QASP), Independent Government Cost Estimate (IGCE) and a Market Research Memorandum (MRM). Furthermore service requirements, due to their nature, require up to a thirty day start up time (after award of the contract, but before the start of performance) to allow for completion of a background check, verification of candidates' security clearance level (Secret and Top Secret) and issuance of a Common Access Cards (CAC). The PALT date for this requirement is 182 days to contract award (after receipt of a complete package) and in order to account for the 30 day start up period, a contract award date of 2 August 2017 is required. To meet the required contract award date of August 2, 2017, a complete requirements package must have been received by NMLC by 01 February 2017. To this end, NMLC initially reached out to NSMRL on 17 November 2016 to request the requirements package. Frequent follow ups were made until the PWS (minus the QASP) and IGCE were received on 07 February 2017. The QASP and MRM were received from NSMRL on 06 March 2017. Ongoing revisions to the PWS and DD254 were not finalized until 05 April 2017. In addition, due to ongoing vacancies in Contract Operations Division (COD) 54 at NMLC (exacerbated by the hiring freeze), COD 54 has been significantly understaffed. The workload has remained at a level consistent with past years when COD 54 was fully staffed. Due to the delay in receiving a complete requirements package from the customer, the revisions that were required once NMLC had received a requirements package and vacancies in COD 54, NMLC will be unable to award this contract in time to prevent a break in services. The services provided under N62645-12-C-4075 and the proposed bridge contract is the primary research support at NSMRL. Failure to complete this bridge contact will cause a detrimental break in services to the vital research efforts conducted by NSMRL. This research is not only critical to the mission of NSMRL and the entire Naval Submarine Force, but to the mission of the United States Department of the Navy as a whole. A sound business case analysis of the present facts cannot support risking the vital research conducted by NSMRL by allowing a break in services. Leidos retains the key personnel from the legacy contract. Leidos is the only company that has the capability, the resources, and the expertise to provide these critical services in time to prevent a costly break in critical R&D support services. 6. Description of Effo1i s Made to Solicit Offers from as Many Offerors as Practicable. The proposedcontract will be synopsized on the Fed.BizOpps we bsite fo r the req uir ed pe ri od o f five days for the Sole Source Notice and fifteen days for Notice of Intent to Sole Source. If another company submits a written interest as a result of the synopsis, the company's capability to provide the required services will be evaluated before the contract with Leidos, Inc. 1s awarded. 7. Detennination of Fair and Reasonable Cost. The Contracting Officer will pe1fo1ma cost analysis in order to detennine that the anticipated cost to the Government of the services covered by this J&A will be fair and reasonable. 8. Actions to Remove Ban iers to Future Competition. The requirement for a NSMRL bridge contract is a one-time requirement. This six-month (plus 3 option months) bridge contract allows for the time necessaiy to fully compete a full five-year (60 month) vehicle for the necessa1y research suppo1i services. This bridge action is being used as a tempora1y means of preventing a gap in critical services to NSMRL while simultaneously allowing the time needed in order for effective, full and open competition to occur.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS